ABSTRACT
Phytomedicines that contain extracts from the leaves of Ginkgo biloba have been used in Germany and France for a fairly long time to treat peripheral vascular disease and disturbances of cerebral function. In Europe, commercially available preparations based on the flavonoid and terpene lactone enriched dry extracts EGb 761 and LI 1370 have annual sales of about $500 million U.S.
